Coverage of both common and rare neoplastic and nonneoplastic diseases of the lung and pleuraFocus primarily on diagnosis with correlations to clinical and radiographic characteristicsClinical and pathologic features summarized in quick reference boxes for fast retrieval of informationHundreds of high-quality photomicrographs and gross photographs depict important pathologic featuresContributions from internationally recognized lung pathologists

Molecular genetic information and personalized medicine applications added throughoutNew classifications and approaches to diagnosis and managementLatest information on next generation sequencingBrand new chapter on COVID-19

Covering both common and rare neoplastic and nonneoplastic diseases of the lung and pleura, Pulmonary Pathology, 3rd Edition, is an essential foundation text for pathologists. This popular volume in the Foundations in Diagnostic Pathology series reflects recent advances in the field, while retaining the easy-to-use template format for quick retrieval of information. Contributions from internationally recognized lung pathologists keep you up to date with the latest information in pathology and pulmonary medicine.

• Focuses primarily on diagnosis, with correlations to clinical and radiographic characteristics.
• Summarizes clinical and pathologic features in quick references boxes throughout the text.
• Contains hundreds of photomicrographs and gross photographs—most in full color—that depict important pathologic features, enabling you to form a differential diagnosis and compare your findings with actual cases.
• Reflects recent advances in molecular genetics and personalized medicine, molecular technologies used for the diagnosis of infectious diseases, next generation sequencing, and the application of molecular technologies to cytopathology.
• Includes a new chapter on COVID-19.

Molecular genetic information and personalized medicine applications added throughoutNew classifications and approaches to diagnosis and managementLatest information on next generation sequencingBrand new chapter on COVID-19